drugset / Trial / NCT00111748
UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The main goal of this study is to evaluate the effectiveness of the combination of these drugs, and whether they can be given safely together.
Timeline
- Start
- 2005-02
- Primary completion
- 2006-09
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bortezomib | Small molecule | 1 mg/m2 | Intravenous |
| Comparator | Dexamethasone | Small molecule | 20 mg | Oral |
| Comparator | Thalidomide | Other / unclassified | 100 mg | Oral |
| Comparator | Enoxaparin sodium | Other / unclassified | 40 mg | Subcutaneous |